How Does Satsuma Pharmaceuticals Inc (STSA) Stock Rank on Wall Street Tuesday?

Tuesday, May 16, 2023 02:16 PM | InvestorsObserver Analysts

Mentioned in this article

How Does Satsuma Pharmaceuticals Inc (STSA) Stock Rank on Wall Street Tuesday?

InvestorsObserver is giving Satsuma Pharmaceuticals Inc (STSA) an Analyst Rating Rank of 21, meaning STSA is ranked higher by analysts than 21% of stocks. The average price target for STSA is $2 and analyst’s rate the stock as a Buy.

Wall Street analysts are rating STSA a Buy today. Find out what this means to you and get the rest of the rankings on STSA!

See Full STSA Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Satsuma Pharmaceuticals Inc Stock Today?

Satsuma Pharmaceuticals Inc (STSA) stock is trading at $1.06 as of 2:03 PM on Tuesday, May 16, a loss of -$0.01, or -0.93% from the previous closing price of $1.07. The stock has traded between $1.05 and $1.08 so far today. Volume today is light. So far 138,799 shares have traded compared to average volume of 1,842,521 shares. Click Here to get the full Stock Report for Satsuma Pharmaceuticals Inc stock.